Ventricular Assist Devices

  • Bradley L. Bufkin
  • Robert A. Guyton


Extracardiac blood pumps may be used to allow temporary circulatory support in circumstances in which the pumping function of the heart is inadequate. Because of the complexity of these devices, the complications associated with their use, and cost considerations, all pharmacologic avenues of myocardial and circulatory support, as well as the intraaortic balloon pump (IABP) (see Chapter 28), are usually tried prior to resorting to ventricular assist devices. This chapter will consider the indications for the use of ventricular assistance, the devices that are appropriate for short-term assistance and those appropriate for longer-term assistance, and the complications associated with these devices.


Pulsatile Flow Circulatory Support Ventricular Assist Device Blood Pump Total Artificial Heart 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pennington DG, Swartz M, Codd JE, et al. Intra-aortic balloon pumping in cardiac surgical patients: a nine-year experience. Ann Thorac Surg 1983;36:125–131.PubMedCrossRefGoogle Scholar
  2. 2.
    Norman JC, Cooley DA, Igo SR, et al. Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping. J Thorac Cardiovasc Surg 1977;74:709–720.PubMedGoogle Scholar
  3. 3.
    Downing TP, Miller DC, Stofer R, et al. Use of the intraaortic balloon pump after valve replacement. J Thorac Cardiovasc Surg 1986;92:210–217.PubMedGoogle Scholar
  4. 4.
    Pennington DG, Merjavy JP, Swartz M, et al. The importance of biventricular failure in patients with postoperative cardiogenic shock. Ann Thorac Surg 1985;39:16–26.PubMedCrossRefGoogle Scholar
  5. 5.
    Rose DM, Colvin SB, Culliford AT, et al. Long-term survival with partial left heart bypass following perioperative myocardial infarction and shock. J Thorac Cardiovasc Surg 1982;83:483–492.PubMedGoogle Scholar
  6. 6.
    Pae WE Jr, Miller CA, Matthews Y, et al. Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience. J Thorac Cardiovasc Surg 1992;104: 541–552.PubMedGoogle Scholar
  7. 7.
    Pennington DG, Farrar DJ, Loisance D, et al. Panel discussion presented at the Circulatory Support Symposium of The Society of Thoracic Surgeons, San Francisco, November 1617,1991. Ann Thorac Surg 1993;55:206–212.PubMedCrossRefGoogle Scholar
  8. 8.
    Pennington DG, Swartz MT. Temporary circulatory support in patients with postcardiotomy cariogenic shock. In: Spence PA, Chitwood WR, eds. Cardiac Surgery: State of the Art Reviews. Vol 5, no 3. Philadelphia: Hanley and Bel-fus; 1991:373–392.Google Scholar
  9. 9.
    Report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives. Heart Transplants: Concerns About Cost, Access, and Availability of Donor Organs. Washington: US General Accounting Office, 1989.Google Scholar
  10. 10.
    Copeland JG, Emery RW, Levinson MM, et al. The role of mechanical support and transplantation in treatment of patients with end-stage cardiomyopathy. Circulation 1985; 72(suppl II):II-7.7–12.Google Scholar
  11. 11.
    Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg 1993;55:276–282.PubMedCrossRefGoogle Scholar
  12. 12.
    Pae WE Jr. Ventricular assist devices and total artificial hearts: a combined registry experience. Ann Thorac Surg 1993;55:295–298.PubMedCrossRefGoogle Scholar
  13. 13.
    Rose DM, Corda M, Dunningham JR, et al. Roller pump ventricular assist device. Quaal SJ, Carter R, eds. Cardiac Mechanical Assistance: Beyond Balloon Pumping. St. Louis: Mosby; 1993:43–66.Google Scholar
  14. 14.
    Hoerr HR Jr, Kraemer MF, Williams JL, et al. In vitro comparison of blood handling by the constrained vortex and twin roller blood pumps. JExtracorp Technol 1987;19:316–321.Google Scholar
  15. 15.
    Oku T, Harasaki H, Smith W, et al. A comparative study of four nonpulsatile pumps. Trans Am Soc Artif Intern Organs 1988;34:500–504.Google Scholar
  16. 16.
    Magovern GJ Jr. The biopump and postoperative circulatory support. Ann Thorac Surg 1993;55:245–249.PubMedCrossRefGoogle Scholar
  17. 17.
    Guyton RA, Schonberger JP, Everts PA, et al. Postcardiotomy shock: clinical evaluation of the BVS 5000 Biventricular Support System. Ann Thorac Surg 1993;56:346–356.PubMedCrossRefGoogle Scholar
  18. 18.
    Taylor KM. Pulsatile perfusion. In: Taylor KM, ed. Cardiopulmonary Bypass: Principles and Management. Cambridge: Cambridge University Press; 1986:85–114.Google Scholar
  19. 19.
    Mavroudis C. To pulse or not to pulse. Ann Thorac Surg 1978;25:259–271.PubMedCrossRefGoogle Scholar
  20. 20.
    Minami K, Korner MM, Vyska K, et al. Effects of pulsatile perfusion on plasma catecholamine levels and hemodynamics during and after cardiac operations with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:82–91.PubMedGoogle Scholar
  21. 21.
    Farrar DG, Compton PG, Dajee H, et al. Right heart function during left heart assist and the effects of volume loading in a canine preparation. Circulation 1984;70:708–716.PubMedCrossRefGoogle Scholar
  22. 22.
    Kormos RL, Gaisor T, Antaki J, et al. Evaluation of right ventricular function during clinical left ventricular assistance. ASAIO Trans 1989;35:547–550.PubMedCrossRefGoogle Scholar
  23. 23.
    Burnett CM, Duncan JM, Frazier OH, et al. Improved multi-organ function after prolonged univentricular support. Ann Thorac Surg 1993;55:65–71.PubMedCrossRefGoogle Scholar
  24. 24.
    US Department of Health and Human Services. Regulatory Requirements for Medical Devices: A Workshop Manual. FDA 89–4165. Rockville, MD: Center for Devices and Radiological Health.Google Scholar
  25. 25.
    Thoratec VAD Clinical Summary In Farrar DJ, ed. Thoratec’s Heartbeat 1993; Vol 7.3:1–12.Google Scholar
  26. 26.
    Farrar DJ, Lawson JH, Litwak P, et al. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant 1990;9:415–422.PubMedGoogle Scholar
  27. 27.
    McCarthy PM, Portner PM, Tobler HG, et al. Clinical experience with the Novacor ventricular assist system. J Thorac Cardiovasc Surg 1991;102:578–587.PubMedGoogle Scholar
  28. 28.
    Portner PM. A totally implantable heart assist system: The Novacor Program. In: Akutsu T, Koyanagi H, eds. Artificial Heart 4. New York: Springer-Verlag; 1993:71–82.Google Scholar
  29. 29.
    Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity and superior survival after heart transplant. Ann Thorac Surg 1994; 56:51–58.CrossRefGoogle Scholar
  30. 30.
    Dasse KA, Chipman SD, Sherman CN, et al. Clinical experience with textured blood contacting surfaces in ventricular assist devices. ASAIO Trans 1987;33:418–425.PubMedGoogle Scholar
  31. 31.
    Burton NA, Lefrak EA, Macmanus Q, et al. A reliable bridge to cardiac transplantation: the TCI left ventricular assist device. Ann Thorac Surg 1993;55:1425–1431.PubMedCrossRefGoogle Scholar
  32. 32.
    Thermo Cardiosystems HeartMate LVAD Experience Report. November 1993. Thermo Cardiosystems Inc.Google Scholar
  33. 33.
    Barzilai B, Davila-Roman VG, Eaton MH, et al. Trans-esophageal echocardiography predicts successful withdrawal of ventricular assist devices. J Thorac Cardiovasc Surg 1992;104:1410–1416.PubMedGoogle Scholar
  34. 34.
    Brack M, Olson JD, Pedersen WR, et al. Transesophageal echocardiography in patients with mechanical circulatory assistance. Ann Thorac Surg 1991;52:1306–1309.PubMedCrossRefGoogle Scholar
  35. 35.
    Sekela ME, Verani MS, Noon GP. Comparison of hemodynamics and ejection fraction during left heart bypass. Ann Thorac Surg 1991;51:804–806.PubMedCrossRefGoogle Scholar
  36. 36.
    Joyce LD, Johnson KE, Toninato CJ, et al. Results of the first 100 patients who received Symbion Total Artificial Hearts as a bridge to cardiac transplantation. Circulation 1989;80:(III)192–201.Google Scholar
  37. 37.
    von Recum AF, Park JB. Permanent percutaneous devices. Crit Rev Bioeng 1981;5:37–77.Google Scholar
  38. 38.
    Shepard RB, Simpson DC, Sharp JF. Energy equivalent pressure. Arch Surg 1966;93:730–740.PubMedGoogle Scholar
  39. 39.
    Takeda J. Experimental study of peripheral circulation during extracorporeal circulation with a special reference to a comparison of pulsatile flow with nonpulsatile flow. Arch Jpn Chir 1960;29:1407–1412.Google Scholar
  40. 40.
    Shepard RB, Kirklin JW. Relation of pulsatile flow to oxygen consumption and other variables during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1969;58:694–702.PubMedGoogle Scholar
  41. 41.
    Jacobs LA, Klopp EH, Seamone W, et al. Improved organ function during cardiac bypass with a roller pump modified to deliver pulsatile flow. J Thorac Cardiovasc Surg 1969;58: 703–712.PubMedGoogle Scholar
  42. 42.
    Taylor KM, Devlin BJ, Mittra SM, et al. Assessment of cerebral damage during open-heart surgery. A new experimental model. Scand J Thorac Cardiovasc Surg 1980;14:197–203.PubMedGoogle Scholar
  43. 43.
    Murkin JM, Farrar K. The influence of pulsatile vs non-pulsatile cardiopulmonary bypass on cerebral blood flow and cerebral metabolism. Anesthesiology 1989;71:A41.CrossRefGoogle Scholar
  44. 44.
    Murkin JM, Martzke JA, Buchan AM, et al. Postoperative neurological and neuropsychological performance are not influenced by mode of pH-management or pulsatility during hypothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. In press.Google Scholar
  45. 45.
    Many M, Soroff HS, Birtwell WC, et al. The physiologic role of pulsatile and nonpulsatile blood flow: II Effects on renal function. Arch Surg 1967;95:762–766.PubMedGoogle Scholar
  46. 46.
    Many M, Soroff HS, Birtwell WC, et al. The physiologic role of pulsatile and non-pulsatile blood flow: III Effects of unilateral renal artery depulsation. Arch Surg 1968;97:917923.Google Scholar
  47. 47.
    Mathie R, Desai J, Taylor KM. Hepatic blood flow and metabolism during pulsatile and non-pulsatile cardiopulmonary bypass. Life Support Syst 1984;2:303–305.Google Scholar
  48. 48.
    Hirofumi I, Yamaguchi A, Takashi I, et al. Evaluation of the pulsatility of a new pulsatile left ventricular assist device - the integrated cardioassist catheter - in dogs. J Thorac Cardiovasc Surg 1994;107:569–575.Google Scholar
  49. 49.
    Taylor KM. Vasopressor release and multiple organ failure in cardiac surgery. Perfusion 1988;3:1–16.CrossRefGoogle Scholar
  50. 50.
    Minami K, Körner MM, Vyska K, et al. Effects of pulsatile perfusion on plasma catecholamine levels and hemodynamics during and after cardiac operation with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:82–91.PubMedGoogle Scholar
  51. 51.
    Taylor KM, Bain WH, Morton JJ. The role of angiotensin II in the development of peripheral vasoconstriction during open-heart surgery. Am Heart J 1980;100:935–937.PubMedCrossRefGoogle Scholar
  52. 52.
    Taylor KM, Casals J, Morton JJ, et al. The haemodynamic effects of angiotensin-converting enzyme inhibition after cardiopulmonary bypass in dogs. Cardiovasc Res 1980;14: 199–205.PubMedCrossRefGoogle Scholar
  53. 53.
    Bregman D, Bowman FO, Parodi EN, et al. An improved method of myocardial protection with pulsation during cardiopulmonary bypass. Circulation (suppl II) 1977;56:157–161.Google Scholar
  54. 54.
    Maddoux G, Pappas G, Jenkins M, et al. Effect of pulsatile and non-pulsatile flow during cardiopulmonary bypass on left ventricular ejection fraction early after aortocoronary bypass surgery. Am J Cardiol 1976;37:1000–1006.PubMedCrossRefGoogle Scholar
  55. 55.
    Taylor KM, Bain WH, Davidson KG, et al. A comparative study of pulsatile and non-pulsatile cardiopulmonary bypass in 325 patients. Proc Eur Soc Artif Org 1979;6:238–242.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1995

Authors and Affiliations

  • Bradley L. Bufkin
  • Robert A. Guyton

There are no affiliations available

Personalised recommendations